Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Haiyong Han

Showing results (41-50 of 99) with videos related to

Pageof 10
Sort By:
Pharmaceutics|August 12, 2018
The Effects of Synthetically Modified Natural Compounds on ABC TransportersDaniel Dantzic, Pawan Noel, Fabrice Merien, et al.
Molecular Cancer Therapeutics|October 17, 2006
Comparing Aurora A and Aurora B as molecular targets for growth inhibition of pancreatic cancer cellsSteven L Warner, Ruben M Munoz, Phillip Stafford, et al.
Molecular Cancer Therapeutics|May 14, 2004
Identification of human polo-like kinase 1 as a potential therapeutic target in pancreatic cancerPhillip J Gray, David J Bearss, Haiyong Han, et al.
Neoplasia (New York, N.Y.)|November 19, 2004
Laminin-5 beta3A expression in LNCaP human prostate carcinoma cells increases cell migration and tumorigenicityRobert Calaluce, David J Bearss, Jean Barrera, et al.
Biomedicines|January 21, 2023
Andrographis Reverses Gemcitabine Resistance through Regulation of ERBB3 and Calcium Signaling Pathway in Pancreatic Ductal AdenocarcinomaKeisuke Okuno, Caiming Xu, Silvia Pascual-Sabater, et al.
Oncotarget|February 14, 2018
Assessment of folate receptor alpha and beta expression in selection of lung and pancreatic cancer patients for receptor targeted therapiesJiayin Shen, Yingwen Hu, Karson S Putt, et al.
Molecular Cancer Therapeutics|December 14, 2002
The cationic porphyrin TMPyP4 down-regulates c-MYC and human telomerase reverse transcriptase expression and inhibits tumor growth in vivoCory L Grand, Haiyong Han, Rubén M Muñoz, et al.
Journal of Controlled Release : Official Journal of the Controlled Release Society|November 13, 2022
Effect of acoustic cluster therapy (ACT®) combined with chemotherapy in a patient-derived xenograft mouse model of pancreatic cancerSerina Ng, Andrew John Healey, Per Christian Sontum, et al.
The Oncologist|December 21, 2020
Analysis of the Role of Plasma 25-Hydroxyvitamin D Levels in Survival Outcomes in Patients from the Phase III MPACT Trial of Metastatic Pancreatic CancerDaniel D Von Hoff, Derek Cridebring, Olivia Yu Tian, et al.
Molecular Cancer Therapeutics|August 8, 2006
Identification of a lead small-molecule inhibitor of the Aurora kinases using a structure-assisted, fragment-based approachSteven L Warner, Sridevi Bashyam, Hariprasad Vankayalapati, et al.
Pageof 10

Showing results (41-50 of 99) with videos related to

Sort By:
Pageof 10
Pharmaceutics|August 12, 2018
The Effects of Synthetically Modified Natural Compounds on ABC TransportersDaniel Dantzic, Pawan Noel, Fabrice Merien, et al.
Molecular Cancer Therapeutics|October 17, 2006
Comparing Aurora A and Aurora B as molecular targets for growth inhibition of pancreatic cancer cellsSteven L Warner, Ruben M Munoz, Phillip Stafford, et al.
Molecular Cancer Therapeutics|May 14, 2004
Identification of human polo-like kinase 1 as a potential therapeutic target in pancreatic cancerPhillip J Gray, David J Bearss, Haiyong Han, et al.
Neoplasia (New York, N.Y.)|November 19, 2004
Laminin-5 beta3A expression in LNCaP human prostate carcinoma cells increases cell migration and tumorigenicityRobert Calaluce, David J Bearss, Jean Barrera, et al.
Biomedicines|January 21, 2023
Andrographis Reverses Gemcitabine Resistance through Regulation of ERBB3 and Calcium Signaling Pathway in Pancreatic Ductal AdenocarcinomaKeisuke Okuno, Caiming Xu, Silvia Pascual-Sabater, et al.
Oncotarget|February 14, 2018
Assessment of folate receptor alpha and beta expression in selection of lung and pancreatic cancer patients for receptor targeted therapiesJiayin Shen, Yingwen Hu, Karson S Putt, et al.
Molecular Cancer Therapeutics|December 14, 2002
The cationic porphyrin TMPyP4 down-regulates c-MYC and human telomerase reverse transcriptase expression and inhibits tumor growth in vivoCory L Grand, Haiyong Han, Rubén M Muñoz, et al.
Journal of Controlled Release : Official Journal of the Controlled Release Society|November 13, 2022
Effect of acoustic cluster therapy (ACT®) combined with chemotherapy in a patient-derived xenograft mouse model of pancreatic cancerSerina Ng, Andrew John Healey, Per Christian Sontum, et al.
The Oncologist|December 21, 2020
Analysis of the Role of Plasma 25-Hydroxyvitamin D Levels in Survival Outcomes in Patients from the Phase III MPACT Trial of Metastatic Pancreatic CancerDaniel D Von Hoff, Derek Cridebring, Olivia Yu Tian, et al.
Molecular Cancer Therapeutics|August 8, 2006
Identification of a lead small-molecule inhibitor of the Aurora kinases using a structure-assisted, fragment-based approachSteven L Warner, Sridevi Bashyam, Hariprasad Vankayalapati, et al.
Pageof 10